Item no. |
BS1037-50 |
Manufacturer |
Bioworld Technology, Inc
|
Amount |
50ul |
Category |
|
Type |
Antibody Polyclonal |
Applications |
WB, IHC |
Specific against |
Human, Mouse, Rat |
Host |
Rabbit |
ECLASS 10.1 |
32160702 |
ECLASS 11.0 |
32160702 |
UNSPSC |
12352203 |
Alias |
CCAAT/enhancer-binding protein beta, C/EBP beta, C/EBPbeta, C/EBP beta, Liver activator protein, LAP, Liver-enriched inhibitory protein, LIP, Nuclear factor NF-IL6, Transcription factor 5, TCF-5, CEBPB, TCF5, ORF Names: PP9092 |
Similar products |
C/EBP-beta |
Available |
|
Swiss-Prot |
P17676 |
Application all |
WB: 1:500ca.1:1000 IHC: 1:50ca.1:200 |
Background |
C/EBP beta is a member of the C/EBP transcription factor family. The C/EBP beta gene encodes several isoforms, which have truncated transcription activation domains by the alternative translational initiation at multipe AUG start sites. Initiation of translation at the in-frame AUGs forms four C/EBP beta isoforms. C/EBP beta is also known as interleukin 6-dependent DNA-binding protein (IL6DBP), liver activator protein(LAP) or liver-enriched transcriptional activator protein transcription factor 5 (TCF5). C/EBP beta contributes to the regulation of the acute phase response in hepatocytes. Stat3 has an important function in IL-6-mediated transcription of the C/EBP beta gene that has direct implication for acute phase response in liver cells.The 35 kDa C/EBP beta form requires phosphorylation for its DNA binding ability, and increased binding of C/EBP beta isoforms during acute-phase reaction occurs through its upregulation and structural modification. |
Product |
1 mg/ml in Phosphate buffered saline (PBS) with 0.05% sodium azide, approx. pH 7.2. |
Purification and Purity |
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE). |
Storage and Stability |
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles. |
Specificity |
C/EBP-beta (S229/182) pAb detects endogenous levels of total C/EBP-beta protein. |
WB |
Western blot (WB) analysis of C/EBP-beta (S229/182) pAb at 1:500 dilution Lane1:Hela cell lysate Lane2:Mouse brain tissue lysate Lane3:Rat kidney tissue lysate |
IHC |
Immunohistochemistry (IHC) analyzes of C/EBP-beta (S229/182) pAb in paraffin-embedded human breast carcinoma tissue at 1:100. |
BiowMW |
ca. 19, 36, 38 kDa |
Note |
For research use only, not for use in diagnostic procedure. |
Alternative Name |
CCAAT/enhancer-binding protein beta, C/EBP beta, C/EBPbeta, C/EBP beta, Liver activator protein, LAP, Liver-enriched inhibitory protein, LIP, Nuclear factor NF-IL6, Transcription factor 5, TCF-5, CEBPB, TCF5, ORF Names: PP9092 |
Immunogen |
Synthetic peptide, corresponding to amino acids 200-250 of Human C/EBP-beta. |
Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.
All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.